title: Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population.
abstract: Genetic and environmental factors contribute to the etiology of neural tube defects (NTDs). While periconceptional folic acid supplementation is known to significantly reduce the risk of NTDs, folate metabolic pathway related factors do not account for all NTDs. Evidence from mouse models indicates that the tumor protein p53 (TP53) is involved in implantation and normal neural tube development. To determine whether genetic variation in TP53 might contribute to NTD risk in humans, we constructed a high resolution linkage disequilibrium (LD) map of the TP53 genomic region based on genotyping 21 markers in an Irish population. We found that nine of these variants can be used to capture the majority of common variation in the TP53 genomic region. In contrast, the 3-marker haplotype commonly reported in the TP53 literature offers limited coverage of the variation in the gene. We used the expanded set of polymorphisms to measure the influence of TP53 on NTDs using both case-control and family based tests of association. We also assayed a functional variant in the p53 regulator MDM2 (rs2279744). Alleles of three noncoding TP53 markers were associated with NTD risk. A case effect was seen with the GG genotype of rs1625895 in intron 6 (OR = 1.37 [1.04-1.79], P = 0.02). A maternal effect was seen with the 135/135 genotype of the intron 1 VNTR (OR = 1.86 [1.16-2.96], P = 0.01) and the TT genotype of rs1614984 (RR = 0.58 [0.37-0.91], P = 0.02). As multiple comparisons were made, these cannot be considered definitive positive findings and additional investigation is required.
authors.affiliation: Molecular Pathogenesis Section, Genome Technology Branch, National Human Genome Research Institute, Bethesda, Maryland 20892-8004, USA.
authors.forename: Faith
authors.initials: F
authors.lastname: Pangilinan
authors.forename: Kerry
authors.initials: K
authors.lastname: Geiler
authors.forename: Jessica
authors.initials: J
authors.lastname: Dolle
authors.forename: James
authors.initials: J
authors.lastname: Troendle
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Swanson
authors.forename: Anne M
authors.initials: AM
authors.lastname: Molloy
authors.forename: Marie
authors.initials: M
authors.lastname: Sutton
authors.forename: Mary
authors.initials: M
authors.lastname: Conley
authors.forename: Peadar N
authors.initials: PN
authors.lastname: Kirke
authors.forename: John M
authors.initials: JM
authors.lastname: Scott
authors.forename: James L
authors.initials: JL
authors.lastname: Mills
authors.forename: Lawrence C
authors.initials: LC
authors.lastname: Brody
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D016022:Case-Control Studies; D002874:Chromosome Mapping; D005260:Female; D016158:Genes, p53; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D007231:Infant, Newborn; D007494:Ireland; D015810:Linkage Disequilibrium; D008297:Male; D009436:Neural Tube Defects / Q000235:genetics*; D011110:Polymorphism, Genetic; D011247:Pregnancy; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics; D016135:Spinal Dysraphism
chemical_list: C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2
references.citation: N Engl J Med. 1999 Nov 11;341(20):1509-19
references.pmid: 10559453
references.citation: J Clin Pathol. 2005 Jan;58(1):26-31
references.pmid: 15623478
references.citation: Q J Med. 1993 Nov;86(11):703-8
references.pmid: 8265769
references.citation: Carcinogenesis. 1996 Jun;17(6):1313-6
references.pmid: 8681448
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):214-22
references.pmid: 17301252
references.citation: Eur J Hum Genet. 2006 Jun;14(6):768-72
references.pmid: 16552426
references.citation: Oncogene. 2004 Mar 11;23(10):1954-6
references.pmid: 14647431
references.citation: Am J Hum Genet. 2003 Nov;73(5):1162-9
references.pmid: 14574645
references.citation: Carcinogenesis. 1995 Sep;16(9):2233-6
references.pmid: 7554081
references.citation: Int J Cancer. 2007 Dec 1;121(11):2532-8
references.pmid: 17683073
references.citation: Hum Hered. 1996 Jan-Feb;46(1):49-54
references.pmid: 8825463
references.citation: Cell. 2004 Nov 24;119(5):591-602
references.pmid: 15550242
references.citation: Am J Hum Genet. 1998 Apr;62(4):969-78
references.pmid: 9529360
references.citation: Am J Hum Genet. 2001 Apr;68(4):978-89
references.pmid: 11254454
references.citation: JAMA. 1996 Apr 10;275(14):1089-92
references.pmid: 8601927
references.citation: QJM. 1995 Nov;88(11):763-6
references.pmid: 8542260
references.citation: N Engl J Med. 1992 Dec 24;327(26):1832-5
references.pmid: 1307234
references.citation: Mutagenesis. 1993 Jul;8(4):275-83
references.pmid: 8377645
references.citation: Genes Dev. 2002 Mar 15;16(6):676-80
references.pmid: 11914272
references.citation: Curr Biol. 1995 Aug 1;5(8):931-6
references.pmid: 7583151
references.citation: JAMA. 1996 Apr 10;275(14):1093-6
references.pmid: 8601928
references.citation: Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3115-20
references.pmid: 8610178
references.citation: Cancer Res. 1994 Sep 15;54(18):4855-78
references.pmid: 8069852
references.citation: Nat Genet. 1999 Oct;23(2):176-84
references.pmid: 10508513
references.citation: Pediatrics. 1990 Jan;85(1):1-9
references.pmid: 2404255
references.citation: Carcinogenesis. 1995 Jul;16(7):1461-4
references.pmid: 7614678
references.citation: Br J Cancer. 1994 Mar;69(3):409-16
references.pmid: 8123467
references.citation: Bioinformatics. 2005 Jan 15;21(2):263-5
references.pmid: 15297300
references.citation: Epidemiology. 1996 Sep;7(5):507-12
references.pmid: 8862982
references.citation: Pediatr Neurosurg. 2000 Jan;32(1):1-9
references.pmid: 10765131
references.citation: Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):105-12
references.pmid: 9037561
references.citation: JAMA. 1995 Dec 6;274(21):1698-702
references.pmid: 7474275
references.citation: Am J Obstet Gynecol. 1994 Feb;170(2):541-8
references.pmid: 8116710
references.citation: Lancet. 1995 Apr 15;345(8955):994
references.pmid: 7715326
references.citation: BMJ. 2005 Mar 12;330(7491):574-5
references.pmid: 15760997
references.citation: Teratology. 1987 Jun;35(3):465-73
references.pmid: 3114906
references.citation: Am J Hum Genet. 2002 Nov;71(5):1207-15
references.pmid: 12384833
references.citation: Am J Epidemiol. 2000 May 1;151(9):862-77
references.pmid: 10791559
references.citation: Br J Cancer. 1999 Sep;81(1):179-83
references.pmid: 10487631
references.citation: Environ Health Perspect. 1997 Jun;105 Suppl 4:919-26
references.pmid: 9255581
references.citation: Birth Defects Res A Clin Mol Teratol. 2006 Feb;76(2):129-32
references.pmid: 16470852
references.citation: Oncogene. 2006 Mar 13;25(11):1602-11
references.pmid: 16550160
references.citation: Cell. 1991 Nov 15;67(4):767-74
references.pmid: 1682057
references.citation: Lancet. 1991 Jul 20;338(8760):131-7
references.pmid: 1677062
references.citation: J Hum Genet. 2006;51(2):98-103
references.pmid: 16315005
references.citation: J Natl Cancer Inst. 2002 May 1;94(9):681-90
references.pmid: 11983757
references.citation: Nature. 2000 Nov 16;408(6810):307-10
references.pmid: 11099028
references.citation: Nat Genet. 1995 Jun;10(2):175-80
references.pmid: 7663512
references.citation: Nature. 2007 Nov 29;450(7170):721-4
references.pmid: 18046411
references.citation: Clin Chem. 1993 Mar;39(3):549-50
references.pmid: 8448878
references.citation: Br J Cancer. 2005 Jan 17;92(1):30-5
references.pmid: 15583690